| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |